
NCNA
Healthcare · Biotechnology · $3.9M market cap
$0.9326+0.00 (+0.3%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2025
EPS trend, 90 days to now · +99.4% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Time not confirmed | — | -0.47 | — |
| Aug 13, 2026 | Time not confirmed | — | -0.99 | — |
| Nov 13, 2025 | Time not confirmed | -13.00 | -0.08 | +99.4% |
| Aug 20, 2025 | Time not confirmed | -13.00 | -23.31 | -79.3% |
| May 14, 2025 | Before the open | -13.00 | -0.51 | +96.1% |
| Mar 20, 2025 | After the close | -440.00 | -64.85 | +85.3% |
| Nov 25, 2024 | Before the open | -790.00 | -439.60 | +44.4% |
| Aug 15, 2024 | After the close | -798.00 | -771.80 | +3.3% |
| May 16, 2024 | After the close | -820.00 | -823.60 | -0.4% |
| Mar 20, 2024 | After the close | -254.95 | -350.00 | -37.3% |
| Nov 16, 2023 | After the close | -612.50 | -807.15 | -31.8% |
| Aug 16, 2023 | After the close | -810.00 | -637.55 | +21.3% |
| May 17, 2023 | After the close | -717.50 |
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate concentrations of anti-cancer metabolites in cancer…
| -935.80 |
| -30.4% |
| Mar 22, 2023 | Time not confirmed | -0.00 | -0.00 | 0.0% |
| Nov 16, 2022 | After the close | -620.00 | -534.70 | +13.8% |
| Aug 17, 2022 | After the close | -752.50 | -421.60 | +44.0% |
| Jun 2, 2022 | After the close | -745.00 | -1004.05 | -34.8% |
| Nov 18, 2021 | After the close | -1226.67 | -1010.45 | +17.6% |
| Aug 19, 2021 | After the close | -1345.00 | -1161.40 | +13.7% |
| May 19, 2021 | After the close | -1143.75 | -1345.00 | -17.6% |
| Mar 4, 2021 | After the close | -16.11 | -24.00 | -49.0% |
| Nov 19, 2020 | After the close | -1217.00 | -1587.55 | -30.4% |
| Aug 19, 2020 | After the close | -1118.00 | -1252.85 | -12.1% |
| May 19, 2020 | After the close | -1149.00 | -734.60 | +36.1% |
| Mar 10, 2020 | After the close | -16.20 | -24.00 | -48.1% |
| Nov 13, 2019 | After the close | -1422.00 | -770.70 | +45.8% |
| Aug 21, 2019 | After the close | -1192.00 | -849.80 | +28.7% |
| May 14, 2019 | After the close | -1306.67 | -1097.45 | +16.0% |
| Mar 7, 2019 | After the close | -19.05 | -11.00 | +42.3% |
| Nov 27, 2018 | After the close | -1401.25 | -509.90 | +63.6% |
| Aug 28, 2018 | After the close | -1311.67 | -257.65 | +80.4% |
| May 23, 2018 | After the close | -1092.50 | -1335.25 | -22.2% |
| Mar 21, 2018 | After the close | -8.90 | -0.73 | +91.8% |